4Schneider J J,Good P,Ravenscroft P J. Effect of tubing on loss of clonazepam administered by continuoussub cutaneousinfusion[J]. J pain Symptom Manage, 2006, 31 (6) :563.
5Kim S C,Yoon H J,Lee J W,et al. Investigation of the release behavior of DEHP from infusion sets by pacli- taxel-loaded polymeric micelles[J]. Int J Pharm, 2005, 293(1) :303.
6I.atini G,De Felice C,Presta G,et al. Exposure to di(2-ethylhexyl) phthalate in humans during pregnancy: A preliminary report[J]. Biol Neonate, 2003,83 ( 1 ) : 22-24.
7Latini G, De Felice C, Presta G. In ulero exposure to di-(2-ethylhexyl) phthalate and duration of human pregnancy[J]. Environ Health Perspect,2003,111(14):1783-1785.
8殷敬华.要慎用DEHP增塑的PVC制作的一次性医用输注器械.健康报,2008,8:24-24.
9A,De Felice C,et al. D1-2-ethylhexyl phthalate and endocrine disruption: A review[J]. Curr Drug Targets Immune Endocr Metabol Disord, 2004,4(1):37-40.
